212 related articles for article (PubMed ID: 10923919)
1. Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver.
Washington K; Wright K; Shyr Y; Hunter EB; Olson S; Raiford DS
Hum Pathol; 2000 Jul; 31(7):822-8. PubMed ID: 10923919
[TBL] [Abstract][Full Text] [Related]
2. Hepatic stellate cell activation occurs in nonalcoholic steatohepatitis.
Cortez-Pinto H; Baptista A; Camilo ME; de Moura MC
Hepatogastroenterology; 2001; 48(37):87-90. PubMed ID: 11269008
[TBL] [Abstract][Full Text] [Related]
3. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.
Carpino G; Morini S; Ginanni Corradini S; Franchitto A; Merli M; Siciliano M; Gentili F; Onetti Muda A; Berloco P; Rossi M; Attili AF; Gaudio E
Dig Liver Dis; 2005 May; 37(5):349-56. PubMed ID: 15843085
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis markers in liver biopsy of nonalcoholic steatohepatitis in pediatric patients.
Valva P; De Matteo E; Galoppo M; Pedreira A; Giacove G; Lezama C; Marco I; Galoppo MC; Preciado MV
Hum Pathol; 2008 Dec; 39(12):1816-22. PubMed ID: 18715620
[TBL] [Abstract][Full Text] [Related]
5. Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study.
Carpino G; Franchitto A; Morini S; Corradini SG; Merli M; Gaudio E
Ital J Anat Embryol; 2004; 109(4):225-38. PubMed ID: 15717457
[TBL] [Abstract][Full Text] [Related]
6. Hepatic stellate cell immunodetection and cirrhotic evolution of viral hepatitis in liver allografts.
Guido M; Rugge M; Leandro G; Fiel IM; Thung SN
Hepatology; 1997 Aug; 26(2):310-4. PubMed ID: 9252139
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic fatty liver disease. Correlation with histology and viral hepatitis.
Akyol G; Erdem O; Yilmaz G
Saudi Med J; 2005 Dec; 26(12):1904-10. PubMed ID: 16380770
[TBL] [Abstract][Full Text] [Related]
8. The value of alpha-SMA in the evaluation of hepatic fibrosis severity in hepatitis B infection and cirrhosis development: a histopathological and immunohistochemical study.
Akpolat N; Yahsi S; Godekmerdan A; Yalniz M; Demirbag K
Histopathology; 2005 Sep; 47(3):276-80. PubMed ID: 16115228
[TBL] [Abstract][Full Text] [Related]
9. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
10. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.
Richardson MM; Jonsson JR; Powell EE; Brunt EM; Neuschwander-Tetri BA; Bhathal PS; Dixon JB; Weltman MD; Tilg H; Moschen AR; Purdie DM; Demetris AJ; Clouston AD
Gastroenterology; 2007 Jul; 133(1):80-90. PubMed ID: 17631134
[TBL] [Abstract][Full Text] [Related]
11. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
[TBL] [Abstract][Full Text] [Related]
12. Hepatic alpha-smooth muscle actin expression in hepatitis C patients before and after interferon therapy.
Khan MA; Poulos JE; Brunt EM; Li L; Solomon H; Britton RS; Bacon BR; Di Bisceglie AM
Hepatogastroenterology; 2001; 48(37):212-5. PubMed ID: 11268968
[TBL] [Abstract][Full Text] [Related]
13. Activated liver stellate cells in chronic viral C hepatitis: histopathological and immunohistochemical study.
Tomanovic NR; Boricic IV; Brasanac DC; Stojsic ZM; Delic DS; Brmbolic BJ
J Gastrointestin Liver Dis; 2009 Jun; 18(2):163-7. PubMed ID: 19565045
[TBL] [Abstract][Full Text] [Related]
14. Liver biopsy in alcoholic and non-alcoholic steatohepatitis patients.
Tiniakos DG
Gastroenterol Clin Biol; 2009; 33(10-11):930-9. PubMed ID: 19646834
[TBL] [Abstract][Full Text] [Related]
15. Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C.
Russo MW; Firpi RJ; Nelson DR; Schoonhoven R; Shrestha R; Fried MW
Liver Transpl; 2005 Oct; 11(10):1235-41. PubMed ID: 16184580
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between the severity of liver damage and the serum leptin level for nonalcoholic fatty liver disease].
Kim KO; Park SH; Park CH; Han TH; Yoo KS; Kim JH; Lee MS; Kim DJ; Park CK; Cho HD
Korean J Hepatol; 2005 Mar; 11(1):51-8. PubMed ID: 15788885
[TBL] [Abstract][Full Text] [Related]
17. Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis.
Chtioui H; Semela D; Ledermann M; Zimmermann A; Dufour JF
Liver Int; 2007 Aug; 27(6):764-71. PubMed ID: 17617119
[TBL] [Abstract][Full Text] [Related]
18. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
[TBL] [Abstract][Full Text] [Related]
19. Differential findings for CD14-positive hepatic monocytes/macrophages in primary biliary cirrhosis, chronic hepatitis C and nonalcoholic steatohepatitis.
Leicester KL; Olynyk JK; Brunt EM; Britton RS; Bacon BR
Liver Int; 2006 Jun; 26(5):559-65. PubMed ID: 16762000
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice.
Nan YM; Fu N; Wu WJ; Liang BL; Wang RQ; Zhao SX; Zhao JM; Yu J
Scand J Gastroenterol; 2009; 44(3):358-65. PubMed ID: 18991162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
